Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Albumin To Enhance Recovery After Acute Kidney Injury: A Multi-Centre, Randomized, Controlled Trial

NCT04705896 is registered in ClinicalTrials.gov with Ottawa Hospital Research Institute as lead sponsor.

NCT NCT04705896
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04705896 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Albumin To Enhance Recovery After Acute Kidney Injury: A Multi-Centre, Randomized, Controlled Trial
Lead sponsor
Ottawa Hospital Research Institute
Phase
Phase 4
Overall status
Recruiting
Start date
November 2, 2023
Completion date
October 23, 2025
Enrollment
856 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, critical illness, hypotension, renal replacement therapy